Results 141 to 150 of about 73,504 (266)

Pneumococcal conjugate vaccines for preventing acute otitis media in children [PDF]

, 2020
Joline LH de Sévaux, Roderick P Venekamp, Vittoria Lutje, Eelko Hak, Anne GM Schilder, Elisabeth A. M. Sanders, Roger Damoiseaux   +6 more
openalex   +1 more source

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study [PDF]

, 2022
Grant A. Mackenzie, Isaac Osei, Rasheed Salaudeen, Ousman Secka, Umberto D’Alessandro, Ed Clarke, Jonas Schmidt-Chanasit, Paul V. Licciardi, Cattram Nguyen, Brian Greenwood, Kim Mulholland   +10 more
openalex   +1 more source

Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland [PDF]

Kristiana Alexandrova Nikolova, Mikael Andersson, Hans‐Christian Slotved, Anders Koch   +3 more
openalex   +1 more source

Should UK Pneumococcal Vaccine Eligibility Criteria Include Alcohol Dependency in Areas with High Alcohol-Related Mortality? [PDF]

, 2018
John D. Mooney, Michael Imarhiagbe, Jonathan Ling   +2 more
openalex   +1 more source

1718. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study [PDF]

, 2023
Kristin L. Andrejko, Ryan Gierke, Jemma V. Rowlands, Jennifer B. Rosen, Ann Thomas, Zachary Landis, María Rosales, Susan Petit, William Schaffner, Corinne Holtzman, Monica M. Farley, Meghan Barnes, Lee H. Harrison, Lesley McGee, Sopio Chochua, Jennifer R. Verani, Adam L. Cohen, Tamara Pilishvili, Miwako Kobyashi   +18 more
openalex   +1 more source

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE

Педиатрическая фармакология, 2009
The article is devoted to one of the serious problems of the today's medicine — pneumococcal infection. The authors show its importance for public health in terms of its influence upon infant and child mortality and in validization.
David G. McIntosh
doaj  

PIN24 THE COST-EFFECTIVENESS OF 23-VALENT PNEUMOCOCCAL VACCINE IN CATALONIA, SPAIN

, 2003
Pedro Plans-Rubió
openalex   +1 more source

Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy [PDF]

, 2019
S. Dirmesropian, Bette Liu, James Wood, C. Raina MacIntyre, Peter McIntyre, Surendra Karki, Sanjay Jayasinghe, Anthony T. Newall   +7 more
openalex   +1 more source

Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018-2021 follow-up 2 survey. [PDF]

PLoS One
Sulis G, Maredia N, Wolfson C, Basta NE.
europepmc   +1 more source

A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Shelly Senders, Nicola P. Klein, Noor Tamimi, Allison Thompson, Gary Baugher, James Trammel, Yahong Peng, Peter C. Giardina, Ingrid L. Scully, Michael W. Pride, Kimberly J. Center, William C. Gruber, Daniel A. Scott   +12 more
openalex   +1 more source